DailyDoctor Archive Specialties Get app
Back to the 11 September 2026 edition

Research · 02 of 05

A three-day window for repair after ischaemic injury, in rodents

Nothing to change today — but the window in which acute injury can still be steered away from chronic disease may be much shorter than post-AKI clinics assume.

Design
Six controlled rodent experiments with pathomics, bulk RNA sequencing, lineage tracing and cell cycle profiling
Population
Wistar rats and C57BL/6J mice with unilateral ischaemic acute kidney injury, plus PAX2/Confetti and PAX8/FUCCI2aR reporter mice
Primary outcome
Kidney function and progression to chronic kidney disease by timing of contralateral nephrectomy
Effect
Nephrectomy at day 3 gave full functional recovery in both species; delays to day 10 or 20 did not prevent progression. Early nephrectomy reduced tubular atrophy, fibrosis and inflammation, expanded tubular progenitor clones and attenuated persistent polyploidisation

Unilateral acute kidney injury in animals recovers remarkably well if the other kidney is removed, and the observation has sat as a curiosity for years. Six rodent studies in rats and mice set out to find why, and when.

Timing turned out to be the whole finding. Nephrectomy on day three after ischaemic injury produced full functional recovery; delaying it to day 10 or day 20 did not prevent progression to chronic disease. Early nephrectomy reduced tubular atrophy, fibrosis and inflammation. Lineage tracing showed it expanded tubular progenitor cell clones beyond what spontaneous repair achieved, and cell cycle analysis showed it attenuated the persistent tubular polyploidisation that follows ischaemia and is thought to drive progression. Transcriptomics identified gene sets specific to nephrectomy-induced repair rather than to recovery generally.

The clinical translation is not to remove kidneys. It is that the injured tubule has a window during which its fate is not yet settled, that the window in these models is days rather than weeks, and that what closes it is a cellular state — polyploidisation — that can in principle be targeted pharmacologically. Any intervention aimed at preventing chronic kidney disease after acute injury may need to be given far earlier than current trials attempt.

  • This is rodent work; no clinical action follows
  • The transferable claim is about timing: days, not weeks, after the insult
  • Note polyploidisation as the proposed mechanism linking acute injury to chronic disease
  • Continue standard post-AKI follow-up: repeat creatinine, urinalysis and blood pressure
  • Watch for trials of anti-fibrotic or anti-polyploidisation agents given within days of injury

Why it matters

It puts a timescale on the transition from acute injury to chronic disease, which is what any preventive trial needs before it can be designed.

Don't overread it

These are rat and mouse experiments; nothing here shows that any intervention in humans within three days alters outcomes.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

ckdaki

Tomorrow morning, before your first patient

One edition a day for nephrology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app